With the Takeda/Shire merger underway, the big question now is whether the older acquirer can combine the two R&D organizations without the kind of disruption that has marked past deals involving big players.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,